Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082, a Next-Generation Anti-SIRPα Monoclonal Antibody for Advanced Solid Tumors
Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's "In Global, For Global" collaboration strategy. NEWARK, Del. and NANJING, China, Feb. 3, 2026...
Changsoft I&I Expands Presence in Japan Through Local Joint Venture and BIM Localization
TOKYO and SEOUL, South Korea, Dec. 22, 2025 /PRNewswire/ -- Changsoft I&I, a provider of Building Information Modeling (BIM) solutions for the construction industry, is expanding its presence in Japan through a locally integrated joint venture...
WSPN Achieves ISO/IEC 27001:2022 Certification, Reinforcing Its Commitment to World-Class Information Security
TORTOLA, British Virgin Islands, Dec. 12, 2025 /PRNewswire/ -- Worldwide Stablecoin Payment Network (WSPN), a leading provider of next-generation stablecoin infrastructure, today announced that it has successfully obtained the ISO/IEC 27001:2022...
Microbio Appoints Paul Brennan as Chair of the Board
BRISBANE, Australia, Nov. 29, 2024 /PRNewswire/ -- Microbio Ltd, the Australian pathogen diagnostics company specialising in innovative molecular diagnostic solutions, has appointed Paul Brennan as Chair of the Board, effective 2nd December 2024....